Deciphering <i>KDM8</i> dysregulation and CpG methylation in hepatocellular carcinoma using multi-omics and machine learning-Reference-Cited by-同舟云学术

Deciphering KDM8 dysregulation and CpG methylation in hepatocellular carcinoma using multi-omics and machine learning

Published:2024-07-02 Issue:13 Volume:16 Page:961-983
ISSN:1750-1911
Container-title:Epigenomics
language:en
Short-container-title:Epigenomics

Author:

Ahmed Firoz¹^ORCID,Mishra Nitish Kumar²^ORCID,Alghamdi Othman A¹^ORCID,Khan Mohammad Imran³⁴^ORCID,Ahmad Aamir⁵^ORCID,Khan Nargis⁶⁷^ORCID,Rehan Mohammad⁶⁷^ORCID

Affiliation:

1. Department of Biological Sciences, College of Science, University of Jeddah, Jeddah, Saudi Arabia

2. Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, 38015, USA

3. Research Center, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia

4. Department of Biochemistry & Molecular Medicine, College of Medicine, Al-Faisal University, Riyadh, Saudi Arabia

5. Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, 3050, Qatar

6. Snyder Institute of Chronic Diseases, Health Research & Innovation Center, Cumming School of Medicine, University of Calgary, Alberta, Canada

7. Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary, Alberta, Canada

Funder

University of Jeddah

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17501911.2024.2374702

Reference83 articles.

1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

2. AASLD guidelines for the treatment of hepatocellular carcinoma

3. Hepatocellular carcinoma

4. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

5. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma